Lisa A. Thompson, PharmD, BCOP

Lisa A. Thompson, PharmD, BCOP

Lisa A. Thompson, PharmD, BCOP, Clinical Pharmacy Specialist in Oncology, Kaiser Permanente, Colorado

Most Recent Articles by Lisa A. Thompson, PharmD, BCOP

Capecitabine Tolerance of EU vs US Patients

Capecitabine Tolerance of EU vs US Patients

By

Why are European patients better able to tolerate high doses of capecitabine than US patients?

Unprotected Sex After Chemotherapy

Unprotected Sex After Chemotherapy

By

How long after receiving chemotherapy should patients wait to have unprotected sex?

New Pharmacy Regulations

New Pharmacy Regulations

By

What impact do the new pharmacy regulations (USP) have on nursing staff?

Olanzapine Use to Prevent Chemotherapy-Induced Nausea and Vomiting

Olanzapine Use to Prevent Chemotherapy-Induced Nausea and Vomiting

By

Why is the antipsychotic olanzapine (Zyprexa) being used to prevent nausea?

FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages

FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages

By

What is being done to address shortages of chemotherapy drugs?

More Articles by Lisa A. Thompson, PharmD, BCOP

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs